TMEFF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.974800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.829780E-01
Normal-vs-Stage2
5.385800E-01
Normal-vs-Stage3
6.964200E-01
Normal-vs-Stage4
9.529600E-01
Stage1-vs-Stage2
1.205760E-01
Stage1-vs-Stage3
4.852000E-01
Stage1-vs-Stage4
1.727170E-01
Stage2-vs-Stage3
8.027400E-01
Stage2-vs-Stage4
5.646400E-01
Stage3-vs-Stage4
6.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.589800E-01
Normal-vs-AfricanAmerican
6.247200E-01
Normal-vs-Asian
6.043600E-01
Caucasian-vs-AfricanAmerican
9.096600E-01
Caucasian-vs-Asian
9.243000E-01
AfricanAmerican-vs-Asian
9.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.460600E-01
Normal-vs-Female
4.653800E-01
Male-vs-Female
8.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.503200E-01
Normal-vs-Age(41-60Yrs)
9.635600E-01
Normal-vs-Age(61-80Yrs)
3.691800E-01
Normal-vs-Age(81-100Yrs)
1.802970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.758420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.955200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.191800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.655500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.478020E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.034200E-01
Normal-vs-Daily Drinker
1.682630E-01
Normal-vs-Weekly Drinker
7.744200E-01
Normal-vs-Occasional Drinker
6.984800E-01
Normal-vs-Social Drinker
5.953800E-01
Non Drinker-vs-Daily Drinker
6.423000E-01
Non Drinker-vs-Weekly Drinker
2.228200E-01
Non Drinker-vs-Occasional Drinker
3.133000E-01
Non Drinker-vs-Social Drinker
4.649000E-01
Daily Drinker-vs-Weekly Drinker
1.078760E-01
Daily Drinker-vs-Occasional Drinker
1.946610E-01
Daily Drinker-vs-Social Drinker
2.598400E-01
Weekly Drinker-vs-Occasional Drinker
8.427800E-01
Weekly Drinker-vs-Social Drinker
6.798400E-01
Occasional Drinker-vs-Social Drinker
8.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.706400E-01
Normal-vs-Grade 2
9.875600E-01
Normal-vs-Grade 3
9.317400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.855900E-02
Grade 1-vs-Grade 3
2.361800E-01
Grade 1-vs-Grade 4
8.706400E-01
Grade 2-vs-Grade 3
5.672800E-01
Grade 2-vs-Grade 4
9.875600E-01
Grade 3-vs-Grade 4
9.317400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.136600E-01
Normal-vs-NonDiabetic
5.032200E-01
Diabetic-vs-NonDiabetic
6.292000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.341800E-01
Normal-vs-NoPancreatitis
5.142800E-01
Pancreatitis-vs-NoPancreatitis
3.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.295600E-01
Normal-vs-N1
6.073000E-01
N0-vs-N1
6.282000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.718200E-01
Normal-vs-TP53-NonMutant
1.433760E-01
TP53-Mutant-vs-TP53-NonMutant
5.517700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
